Your browser doesn't support javascript.
loading
Drug-induced eosinophilic pneumonia in a patient with Crohn's disease: diagnosis and treatment using fraction of exhaled nitric oxide
Intestinal Research ; : 529-534, 2017.
Article in English | WPRIM | ID: wpr-220093
ABSTRACT
Oral 5-aminosalicylic acid agents (mesalazine and sulfasalazine) and azathioprine are the mainstays of treatment for inflammatory bowel disease. Reports of pulmonary toxicity induced by oral 5-aminosalicylic acid agents or azathioprine in patients with inflammatory bowel disease are very rare; to date, only 38 cases have been reported worldwide. We, herein, report a case involving a 26-year-old man who was diagnosed with eosinophilic pneumonia after using mesalazine and azathioprine for the treatment of Crohn's disease and recovered after treatment. We also found that the fraction of exhaled nitric oxide level was elevated in this patient. After treatment, the fraction of exhaled nitric oxide level decreased and the symptoms improved. The present case shows that fraction of exhaled nitric oxide is related to the disease activity and treatment effectiveness of druginduced eosinophilic pneumonia.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Pulmonary Eosinophilia / Azathioprine / Inflammatory Bowel Diseases / Crohn Disease / Treatment Outcome / Mesalamine / Diagnosis / Eosinophils / Nitric Oxide Type of study: Diagnostic study Limits: Adult / Humans Language: English Journal: Intestinal Research Year: 2017 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Pulmonary Eosinophilia / Azathioprine / Inflammatory Bowel Diseases / Crohn Disease / Treatment Outcome / Mesalamine / Diagnosis / Eosinophils / Nitric Oxide Type of study: Diagnostic study Limits: Adult / Humans Language: English Journal: Intestinal Research Year: 2017 Type: Article